{
    "title": "Pfizer stops enrollment in Paxlovid trial in standard-risk population",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10917047/Pfizer-stops-enrollment-Paxlovid-trial-standard-risk-population.html",
    "date": "2022-06-14",
    "keywords": [
        "drug",
        "standardrisk",
        "study",
        "highrisk",
        "risk",
        "health",
        "june",
        "inc",
        "tuesday",
        "enrollment",
        "trial",
        "paxlovid",
        "treatment",
        "group",
        "emergency",
        "use",
        "authorization",
        "reduction",
        "company",
        "population",
        "disease",
        "pfizer",
        "companys",
        "application",
        "food",
        "administration",
        "approval",
        "israel",
        "month",
        "hospitalization",
        "death",
        "illness",
        "assistant",
        "secretary",
        "preparedness",
        "response",
        "department",
        "amp",
        "reporting",
        "leo",
        "bengaluru",
        "editing",
        "vinay",
        "dwivedi"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}